Identification | Back Directory | [Name]
3-BROMO-4-FLUORO-BENZOIC ACID METHYL ESTER | [CAS]
82702-31-6 | [Synonyms]
RARECHEM AL BF 0277 Methyl 3-bromo-4-fluorobenzene METHYL 3-BROMO-4-FLUOROBENZOATE 3-bromo-4-fluoro-2-methylbenzoate Methyl3-bromo-4-fluorobenzoate98% Methyl 3-bromo-4-fluorobenzoate 98% 3-BROMO-4-FLUORO-BENZOIC ACID METHYL ESTER Benzoic acid, 3-bromo-4-fluoro-, methyl ester | [Molecular Formula]
C8H6BrFO2 | [MDL Number]
MFCD04972915 | [MOL File]
82702-31-6.mol | [Molecular Weight]
233.03 |
Chemical Properties | Back Directory | [Melting point ]
26-28 | [Boiling point ]
245.3±20.0 °C(Predicted) | [density ]
1.577±0.06 g/cm3(Predicted) | [storage temp. ]
Keep Cold | [form ]
powder to lump | [color ]
White to Orange to Green | [InChI]
InChI=1S/C8H6BrFO2/c1-12-8(11)5-2-3-7(10)6(9)4-5/h2-4H,1H3 | [InChIKey]
JVORYGNKYAXATM-UHFFFAOYSA-N | [SMILES]
C(OC)(=O)C1=CC=C(F)C(Br)=C1 |
Hazard Information | Back Directory | [Chemical Properties]
off-white powder | [Synthesis]
a) Synthesis of methyl 3-bromo-4-fluorobenzoate
3-Bromo-4-fluorobenzoic acid (3.33 g, 15.2 mmol) was dissolved in methanol (30 mL) and acetyl chloride (4.3 mL, 60.8 mmol) was added slowly and dropwise under cooling in an ice bath. The reaction mixture was stirred at room temperature for 20 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (eluent: hexane/ethyl acetate) to afford methyl 3-bromo-4-fluorobenzoate (3.2 g, 90% yield) as a colorless oil.1H-NMR (CDCl3) δ: 3.92 (3H, s), 7.18 (1H, dd, J = 8.0, 8.2 Hz), 7.99 (1H, ddd, J = 1.9, 4.9, 8.0 Hz), 7.99 (1H, ddd, J = 1.9, 4.9, 8.0 Hz). 4.9, 8.0 Hz), 8.27 (1H, dd, J = 1.9, 6.5 Hz). | [References]
[1] European Journal of Medicinal Chemistry, 2007, vol. 42, # 11-12, p. 1334 - 1357 [2] Patent: US2010/280013, 2010, A1. Location in patent: Page/Page column 16 [3] Journal of Enzyme Inhibition and Medicinal Chemistry, 2012, vol. 27, # 5, p. 658 - 665,8 [4] Patent: WO2007/99171, 2007, A2. Location in patent: Page/Page column 55 [5] ACS Medicinal Chemistry Letters, 2013, vol. 4, # 3, p. 358 - 362 |
|
|